Steve Curtis

Steve Curtis is the Director of New Ventures at BrightEdge at the American Cancer Society. Steve has over 20 years of experience in business development and has held various positions at NextPoint Therapeutics, Inc., Dyne Therapeutics, MPM Capital, and Eli Lilly and Company.

Steve Curtis completed their undergraduate studies at Cornell University, where they earned a Bachelor of Science in Molecular and Cellular Biology and Applied Economics and Management. Steve then went on to earn their Doctor of Philosophy in Biological and Biomedical Sciences from Harvard Medical School.

Their manager is Alice L. Pomponio, Managing Director, BrightEdge. Steve Curtis works with Daniel Coley - Associate, BrightEdge, Cheryl Ahlquist - Senior Executive Assistant, BrightEdge.